Refine by
Gynecologist Articles & Analysis: Older
96 news found
Laser therapy is transforming clinical medicine, offering innovative solutions for skin therapy, cervical surgery, and gynecological procedures. Advanced equipment, such as specialized gynecology tables and rotary vane medical vacuum pumps, enhances precision and patient comfort in surgical settings. In diagnostics, the use of antigen rapid test kits and in vitro diagnostic hematology is ...
In this piece, we talked to the two presenters of the poster “The Validation of a Homologous Recombination Deficiency Assay into Clinical Practice within the NHS”, Elizabeth Ratsma, Pre-Registration Clinical Scientist – Cancer Genomics and Charlotte Flanagan, PhD, Innovation Lead, from The Royal Marsden NHS Foundation Trust. The poster was recently presented at the ESMO ...
Recently, the Ministry of Industry and Information Technology, the National Health Commission and other 17 departments jointly issued the "robot" application action implementation plan to encourage the development of surgery, auxiliary examination, auxiliary rounds, intensive care, rehabilitation and other medical robot products, "robot The "robot" has ushered in a new round of development ...
JUNE Medical is delighted to announce a new agreement with a major US hospital group to supply the award-winning Galaxy II® self-retaining surgical retractors to over 1,600 hospitals in the US, commencing April 15, 2023. This game-changing device radically improves the safety and ease of surgical retraction for both patients and medical staff; its ergonomic design transforms the way in which ...
The best fractional CO2 laser machine is a minimally invasive treatment. It works by heating the dermis and epidermis with a fractional laser, causing microscopic columnar damage to the skin, activating fibroblasts, stimulating collagen remodelling reactions, thickening the dermis and achieving cosmetic results such as wrinkle reduction, skin rejuvenation and spot removal. Today the CO2 laser ...
MorphoSys AG (FSE: MOR; NASDAQ: MOR) today announced that preliminary results from the ongoing Phase 1/2 study (NCT04104776) of tulmimetostat (CPI-0209) monotherapy in heavily pretreated patients with advanced cancers showed responses or disease stabilization in five cohorts with evaluable patients. Tulmimetostat is an oral, investigational next-generation selective dual inhibitor of EZH2 and ...
PHILADELPHIA, Dec. 08, 2022 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a women’s oncology company developing novel treatments for breast and gynecologic cancers, announced preliminary Phase 2 data from the ongoing SMILE trial of onapristone extended release (ONA-XR), the company’s novel, first-in-class, potent, ...
Onconova Therapeutics, Inc. (NASDAQ: ONTX), (“Onconova”), a clinical-stage biopharmaceutical company focused on discovering and developing novel products for patients with cancer, today announced plans for a Phase 1/2a trial of narazaciclib combined with letrozole in recurrent metastatic low-grade endometrioid endometrial cancer (LGEEC). In addition, the Company reported its third ...
Study plans to investigate elinzanetant as non-hormonal treatment for vasomotor symptoms caused by endocrine therapy in breast cancer patients Elinzanetant is an innovative non-hormonal development compound in development for the treatment of vasomotor symptoms during menopause Bayer, a global leader in women’s healthcare, announced today that it expands the Phase III clinical ...
ByBayer AG
The eight-year data from the extension trial were published in abstract form at the American College of Obstetricians and Gynecologists (ACOG) in 2022. The full paper is published in the American Journal of Obestetrics and Gynecology at. ...
ByBayer AG
Today we’d like to introduce you to Gillian Henker. Hi Gillian, we’re thrilled to have a chance to learn your story today. So, before we get into specifics, maybe you can briefly walk us through how you got to where you are today. In 2014, Gillian Henker co-founded Sisu Global, leading the company’s products and technical strategy. Henker is the primary inventor of Hemafuse ...
According to the American College of Obstetricians and Gynecologists, immersion in water throughout the first stage of labor can be associated with a shorter labor process and less need for spinal and epidural analgesia. ...
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that it has completed its previously announced acquisition of privately-held Biorez, Inc. Biorez is a medical device start-up based in New Haven, CT and is focused on advancing the healing of soft tissue using its proprietary BioBrace® Implant technology. The BioBrace Implant is an innovative bioinductive ...
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced a definitive agreement to acquire privately held Biorez, Inc. (Biorez), on a cash-free, debt-free basis, for cash consideration of $85 million at closing, subject to adjustment, and up to an additional $165 million in growth-based earnout payments over a four-year period. The transaction is expected to be ...
On-demand robotics is a new technique for laparoscopic surgery. It has been used in Germany for the first time by the Department for Women’s Health and Gynecology at the University Hospital Tübingen. Together with the University Hospital Tübingen we announced today the successful completion of gynecological surgeries using Dexter®. This marks Dexter’s first clinical ...
Aresus Pharma GmbH, a subsidiary of DERMAGO GmbH, announced today that clinical results on the efficacy of 5-10% Topical Sinecatechins (synonyms: “Polyphenon® E“, ”defined extract from green tea leaves“) Ointment for Postmenopausal Vestibulodynia1 were presented at the 2nd Congress on Women’s Health Innovations & Inventions in Tel Aviv on July 11-12th, 2022. ...
Saintonge Hospital is the first institution worldwide to introduce on-demand robotics with Dexter® in routine daily use. Dr. Damien Emeriau and Dr. Guillaume Hugues from the urology department of Saintonge Hospital welcomed the Sud-Ouest newspaper into their OR, to explain how on-demand robotics with Dexter has changed their daily practice. Dr. Emeriau comments on the superior precision ...
As a leading company for AI-Driven IVD equipments, Reetoo will be attending AACC (American Association for Clinical Chemistry), which will take place at the McCormick Place Convention Center in Chicago from July 26 to 28. We will bring our latest products to the exhibition as below, and look forward to meeting you at our booth #4060. RT-F600: Automatic Vaginal Secretion Analyzer ...
Barely two months after becoming the first hospital in France to install Dexter®, the team at Saintonge Hospital has scaled its on-demand robotics program into daily use. On pace to carry out 2-3 procedures per day with Dexter between the urology, gynecology and general surgery team, Saintonge Hospital’s pioneering effort is making meaningful progress towards establishing a new standard ...
People who complete the test receive a customised report based on their answers that they can bring to their doctors for further discussion. Dr. Laura Luse, a gynecologist who helped create the test, noted, “With more and more aspects of our lives moving to the virtual realm, it is vital that people have access to reliable, evidence-based information online about ...